Literature DB >> 24945601

Intranasally administered mesenchymal stem cells promote a regenerative niche for repair of neonatal ischemic brain injury.

Vanessa Donega1, Cora H Nijboer1, Geralda van Tilborg2, Rick M Dijkhuizen2, Annemieke Kavelaars3, Cobi J Heijnen4.   

Abstract

Previous work from our group has shown that intranasal MSC-treatment decreases lesion volume and improves motor and cognitive behavior after hypoxic-ischemic (HI) brain damage in neonatal mice. Our aim was to determine the kinetics of MSC migration after intranasal administration, and the early effects of MSCs on neurogenic processes and gliosis at the lesion site. HI brain injury was induced in 9-day-old mice and MSCs were administered intranasally at 10days post-HI. The kinetics of MSC migration were investigated by immunofluorescence and MRI analysis. BDNF and NGF gene expression was determined by qPCR analysis following MSC co-culture with HI brain extract. Nestin, Doublecortin, NeuN, GFAP, Iba-1 and M1/M2 phenotypic expression was assessed over time. MRI and immunohistochemistry analyses showed that MSCs reach the lesion site already within 2h after intranasal administration. At 12h after administration the number of MSCs at the lesion site peaks and decreases significantly at 72h. The number of DCX(+) cells increased 1 to 3days after MSC administration in the SVZ. At the lesion, GFAP(+)/nestin(+) and DCX(+) expression increased 3 to 5days after MSC-treatment. The number of NeuN(+) cells increased within 5days, leading to a dramatic regeneration of the somatosensory cortex and hippocampus at 18days after intranasal MSC administration. Interestingly, MSCs expressed significantly more BDNF gene when exposed to HI brain extract in vitro. Furthermore, MSC-treatment resulted in the resolution of the glial scar surrounding the lesion, represented by a decrease in reactive astrocytes and microglia and polarization of microglia towards the M2 phenotype. In view of the current lack of therapeutic strategies, we propose that intranasal MSC administration is a powerful therapeutic option through its functional repair of the lesion represented by regeneration of the cortical and hippocampal structure and decrease of gliosis.
Copyright © 2014. Published by Elsevier Inc.

Entities:  

Keywords:  Microglia polarization; Nasal MSC therapy; Neonatal hypoxia–ischemia; Neurogenesis; Neuroregeneration; Scar formation

Mesh:

Substances:

Year:  2014        PMID: 24945601     DOI: 10.1016/j.expneurol.2014.06.009

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  46 in total

Review 1.  Emerging roles of extracellular vesicles in neurodegenerative disorders.

Authors:  Yang You; Tsuneya Ikezu
Journal:  Neurobiol Dis       Date:  2019-06-20       Impact factor: 5.996

2.  siRNA Therapeutics for Protein Misfolding Diseases of the Central Nervous System.

Authors:  Mark D Zabel; Luke Mollnow; Heather Bender
Journal:  Methods Mol Biol       Date:  2021

Review 3.  Promoting neuroregeneration after perinatal arterial ischemic stroke: neurotrophic factors and mesenchymal stem cells.

Authors:  Nienke Wagenaar; Caroline G M de Theije; Linda S de Vries; Floris Groenendaal; Manon J N L Benders; Cora H A Nijboer
Journal:  Pediatr Res       Date:  2017-11-01       Impact factor: 3.756

4.  Delayed intranasal infusion of human amnion epithelial cells improves white matter maturation after asphyxia in preterm fetal sheep.

Authors:  Lotte G van den Heuij; Mhoyra Fraser; Suzanne L Miller; Graham Jenkin; Euan M Wallace; Joanne O Davidson; Christopher A Lear; Rebecca Lim; Guido Wassink; Alistair J Gunn; Laura Bennet
Journal:  J Cereb Blood Flow Metab       Date:  2017-09-12       Impact factor: 6.200

Review 5.  Stem cells and cell-based therapies for cerebral palsy: a call for rigor.

Authors:  Lauren L Jantzie; Joseph Scafidi; Shenandoah Robinson
Journal:  Pediatr Res       Date:  2017-11-01       Impact factor: 3.756

Review 6.  Glial progenitor cell-based treatment of the childhood leukodystrophies.

Authors:  M Joana Osorio; Steven A Goldman
Journal:  Exp Neurol       Date:  2016-05-08       Impact factor: 5.330

7.  Mesenchymal Stem Cells Therapy Improved the Streptozotocin-Induced Behavioral and Hippocampal Impairment in Rats.

Authors:  María F Zappa Villar; Juliette López Hanotte; Joaquín Pardo; Gustavo R Morel; Guillermo Mazzolini; Mariana G García; Paula C Reggiani
Journal:  Mol Neurobiol       Date:  2019-08-10       Impact factor: 5.590

Review 8.  Radiation Toxicity in the Central Nervous System: Mechanisms and Strategies for Injury Reduction.

Authors:  DeeDee Smart
Journal:  Semin Radiat Oncol       Date:  2017-10       Impact factor: 5.934

9.  Synergistic and Superimposed Effect of Bone Marrow-Derived Mesenchymal Stem Cells Combined with Fasudil in Experimental Autoimmune Encephalomyelitis.

Authors:  Jing-Wen Yu; Yan-Hua Li; Guo-Bin Song; Jie-Zhong Yu; Chun-Yun Liu; Jian-Chun Liu; Hai-Fei Zhang; Wan-Fang Yang; Qing Wang; Ya-Ping Yan; Bao-Guo Xiao; Cun-Gen Ma
Journal:  J Mol Neurosci       Date:  2016-08-30       Impact factor: 3.444

Review 10.  Stem cell therapy in intracerebral hemorrhage rat model.

Authors:  Marcos F Cordeiro; Ana P Horn
Journal:  World J Stem Cells       Date:  2015-04-26       Impact factor: 5.326

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.